Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

Knowledge

  1. Home>
  2. News>
  3. Knowledge>
  4. Page 6

India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know

  • Post published:August 30, 2026
  • Post category:Knowledge

India has set ambitious goals for its pharmaceutical sector: becoming the "pharmacy of the world" for generic medicines, expanding into complex generics and biosimilars, and boosting exports to $50 billion…

Continue Reading India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know

Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

  • Post published:August 28, 2026
  • Post category:Knowledge

India's pharmaceutical regulatory framework has undergone significant transformation in recent years, with the Central Drugs Standard Control Organisation (CDSCO) and the Pharmacovigilance Programme of India (PvPI) playing increasingly active roles…

Continue Reading Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

CDSCO Bans Injectable Drugs for Cosmetic Use: What Indian Consumers Should Know

  • Post published:August 26, 2026
  • Post category:Knowledge

On May 21, 2026, India's Central Drugs Standard Control Organisation (CDSCO) issued a clear directive: no injectable product can be classified or sold as a cosmetic. The directive, reported by…

Continue Reading CDSCO Bans Injectable Drugs for Cosmetic Use: What Indian Consumers Should Know

Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

  • Post published:August 24, 2026
  • Post category:Knowledge

India's pharmaceutical industry supplies over 20% of the world's generic medicines by volume. For international buyers — hospitals, pharmacies, procurement agencies, and individual patients — the safety and quality of…

Continue Reading Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide
  • Go to the previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 69
  • Go to the next page

Recent Posts

  • How India Trains Drug Inspectors: WHO Fellowship & GMP Checks
    November 17, 2026/
    0 Comments
  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • How India Trains Drug Inspectors: WHO Fellowship & GMP Checks
  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve